Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(3R,4R,5R,6S),N-(4,5,6-trihydroxyazepan-3-yl)-acetamide | 68% inhibition at 1 mM | Bos taurus | |
(3R,4R,5R,6S)-N-(4,5,6-trihydroxy-azepan-3-yl)-acetamide | 93% inhibition at 1 mM | Canavalia sp. | |
(3R,4S,5R,6R,7R),N-(3,5,6-trihydroxy-7-hydroxymethyl-azepan-4-yl)-acetamide | 99% inhibition at 1 mM | Bos taurus | |
(3R,4S,5R,6R,7R),N-(3,5,6-trihydroxy-7-hydroxymethyl-azepan-4-yl)-acetamide | 98% inhibition at 1 mM | Canavalia sp. | |
(3S,4R,5R,6R,7R),N-(3,5,6-trihydroxy-7-hydroxymethyl-azepan-4-yl)-acetamide | 93% inhibition at 1 mM | Bos taurus | |
(3S,4R,5R,6R,7R),N-(3,5,6-trihydroxy-7-hydroxymethyl-azepan-4-yl)-acetamide | 98% inhibition at 1 mM | Canavalia sp. | |
(3S,4R,5R,6R,7R),N-(4,5,6-trihydroxy-7-hydroxymethyl-azepan-3-yl)-acetamide | 74% inhibition at 1 mM | Bos taurus | |
(3S,4R,5R,6R,7R),N-(4,5,6-trihydroxy-7-hydroxymethyl-azepan-3-yl)-acetamide | 88% inhibition at 1 mM | Canavalia sp. | |
(3S,4R,5R,6R,7S),N-(3,5,6-trihydroxy-7-hydroxymethyl-azepan-4-yl)-acetamide | 99% inhibition at 1 mM | Bos taurus | |
(3S,4R,5R,6R,7S),N-(3,5,6-trihydroxy-7-hydroxymethyl-azepan-4-yl)-acetamide | 100% inhibition at 1 mM | Canavalia sp. | |
(3S,4R,5R,6S),N-(4,5,6-trihydroxyazepan-3-yl)-acetamide | 99% inhibition at 1 mM | Bos taurus | |
additional information | design and synthesis of acetamido tri- and tetra-hydroxyazepanes as potent and selective beta-N-acetylhexosaminidase inhibitors | Bos taurus | |
additional information | design and synthesis of acetamido tri- and tetra-hydroxyazepanes as potent and selective beta-N-acetylhexosaminidase inhibitors | Canavalia sp. | |
N-(3R,4S,5R,6R,7S)-(3,5,6-trihydroxy-7-hydroxymethyl-azepan-4-yl)-acetamide | 40% inhibition at 1 mM | Bos taurus | |
N-(3R,4S,5R,6R,7S)-(3,5,6-trihydroxy-7-hydroxymethyl-azepan-4-yl)-acetamide | 91% inhibition at 1 mM | Canavalia sp. | |
N-[(3S,4R,5R,6S)-4,5,6-trihydroxyazepan-3-yl]acetamide | - |
Bos taurus | |
N-[(3S,4R,5R,6S)-4,5,6-trihydroxyazepan-3-yl]acetamide | 99% inhibition at 1 mM | Canavalia sp. |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
lysosome | - |
Bos taurus | 5764 | - |
lysosome | - |
Canavalia sp. | 5764 | - |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | Bos taurus | N-acetyl-beta-hexosaminidases catalyze the hydrolysis of nonreducing terminal N-acetyl-beta-D-glucosamine and N-acetyl-beta-D-galactosamine units in glycoproteins, GM2-gangliosides and glycosaminoglycans including chondroitin 4-sulfate, chondroitin 6-sulfate, hyaluronic acid, keratan sulfate and dermatan sulfate | ? | - |
? | |
additional information | Canavalia sp. | N-acetyl-beta-hexosaminidases catalyze the hydrolysis of nonreducing terminal N-acetyl-beta-D-glucosamine and N-acetyl-beta-D-galactosamine units in glycoproteins, GM2-gangliosides and glycosaminoglycans including chondroitin 4-sulfate, chondroitin 6-sulfate, hyaluronic acid, keratan sulfate and dermatan sulfate | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Bos taurus | - |
- |
- |
Canavalia sp. | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
liver | - |
Bos taurus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | N-acetyl-beta-hexosaminidases catalyze the hydrolysis of nonreducing terminal N-acetyl-beta-D-glucosamine and N-acetyl-beta-D-galactosamine units in glycoproteins, GM2-gangliosides and glycosaminoglycans including chondroitin 4-sulfate, chondroitin 6-sulfate, hyaluronic acid, keratan sulfate and dermatan sulfate | Bos taurus | ? | - |
? | |
additional information | N-acetyl-beta-hexosaminidases catalyze the hydrolysis of nonreducing terminal N-acetyl-beta-D-glucosamine and N-acetyl-beta-D-galactosamine units in glycoproteins, GM2-gangliosides and glycosaminoglycans including chondroitin 4-sulfate, chondroitin 6-sulfate, hyaluronic acid, keratan sulfate and dermatan sulfate | Canavalia sp. | ? | - |
? |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.00005 | - |
(3S,4R,5R,6R,7S),N-(3,5,6-trihydroxy-7-hydroxymethyl-azepan-4-yl)-acetamide | - |
Canavalia sp. | |
0.0004 | - |
N-[(3S,4R,5R,6S)-4,5,6-trihydroxyazepan-3-yl]acetamide | - |
Canavalia sp. | |
0.0004 | - |
(3S,4R,5R,6R,7S),N-(3,5,6-trihydroxy-7-hydroxymethyl-azepan-4-yl)-acetamide | - |
Bos taurus | |
0.0005 | - |
(3R,4S,5R,6R,7R),N-(3,5,6-trihydroxy-7-hydroxymethyl-azepan-4-yl)-acetamide | - |
Canavalia sp. | |
0.0006 | - |
(3R,4S,5R,6R,7R),N-(3,5,6-trihydroxy-7-hydroxymethyl-azepan-4-yl)-acetamide | - |
Bos taurus | |
0.0007 | - |
N-[(3S,4R,5R,6S)-4,5,6-trihydroxyazepan-3-yl]acetamide | - |
Bos taurus | |
0.003 | - |
(3S,4R,5R,6R,7R),N-(3,5,6-trihydroxy-7-hydroxymethyl-azepan-4-yl)-acetamide | - |
Canavalia sp. | |
0.0089 | - |
N-(3R,4S,5R,6R,7S)-(3,5,6-trihydroxy-7-hydroxymethyl-azepan-4-yl)-acetamide | - |
Canavalia sp. | |
0.026 | - |
(3S,4R,5R,6R,7R),N-(3,5,6-trihydroxy-7-hydroxymethyl-azepan-4-yl)-acetamide | - |
Bos taurus | |
0.03 | - |
(3S,4R,5R,6R,7R),N-(4,5,6-trihydroxy-7-hydroxymethyl-azepan-3-yl)-acetamide | - |
Canavalia sp. |